Scilex Holding (SCLXW) Other Working Capital Changes (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Other Working Capital Changes of $1.6 million in Q1 2026, down 76.3% quarter-over-quarter from $6.8 million in Q4 2025, and up 1351.16% on a YoY basis from $111221.2 in Q1 2025.

Scilex Holding (SCLXW) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Scilex Holding's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 1351.16% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.7 million (up 241.9% YoY), while the FY2025 annual figure was -$13000.0, down 101.97% from the prior year.
  • Other Working Capital Changes was $1.6 million for Q1 2026 at Scilex Holding, down from $6.8 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $6.8 million in Q4 2025 to a low of -$6.9 million in Q3 2025.
  • Historically, Other Working Capital Changes has averaged $309250.0 across 5 years, with a median of $116500.0 in 2024.
  • Biggest YoY gain for Other Working Capital Changes was 2431.6% in 2025; the steepest drop was 2135.4% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$849000.0 in 2022, then climbed by 20.61% to -$674000.0 in 2023, then surged by 139.91% to $269000.0 in 2024, then soared by 2431.6% to $6.8 million in 2025, then slumped by 76.3% to $1.6 million in 2026.
  • The last three Other Working Capital Changes figures came in at $1.6 million (Q1 2026), $6.8 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.61 Mn
Mar 31, 2026 1.61 Mn
Dec 31, 2025 6.81 Mn
Dec 31, 2025 6.81 Mn
Sep 30, 2025 -6.90 Mn
Sep 30, 2025 -6.90 Mn
Jun 30, 2025 206,000.00
Jun 30, 2025 206,000.00
Mar 31, 2025 -129,000.00
Mar 31, 2025 -129,000.00
Dec 31, 2024 269,000.00
Dec 31, 2024 269,000.00
Sep 30, 2024 339,000.00
Sep 30, 2024 339,000.00
Jun 30, 2024 27,000.00
Jun 30, 2024 27,000.00
Mar 31, 2024 26,000.00
Mar 31, 2024 26,000.00
Dec 31, 2023 -674,000.00
Dec 31, 2023 -674,000.00